What Comes Next? Industry Takeaways from FDA’s Cell and Gene Therapy Listening Session

What Comes Next? Industry Takeaways from FDA’s Cell and Gene Therapy Listening Session

Register Now Panelists: Paris Margaritis, PhD Chief Scientific OfficerGeneVentiv Therapeutics View Bio Panelist Paris Margaritis, PhD Paris Margaritis, PhD, is a professional with over 28 years of experience in AAV gene therapy for hemophilia. A key focus of his work has been treating hemophilia patients with inhibitors. He earned his doctorate from the University of Oxford and has worked at the Children’s Hospital of Philadelphia and the Univ…